A module map showing conditional activity of expression modules in cancer

被引:522
作者
Segal, E
Friedman, N
Koller, D [1 ]
Regev, A
机构
[1] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA
[2] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel
[3] Harvard Univ, Bauer Ctr Genom Res, Cambridge, MA 02138 USA
基金
美国国家科学基金会;
关键词
D O I
10.1038/ng1434
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA microarrays are widely used to study changes in gene expression in tumors, but such studies are typically system-specific and do not address the commonalities and variations between different types of tumor. Here we present an integrated analysis of 1,975 published microarrays spanning 22 tumor types. We describe expression profiles in different tumors in terms of the behavior of modules, sets of genes that act in concert to carry out a specific function. Using a simple unified analysis, we extract modules and characterize gene-expression profiles in tumors as a combination of activated and deactivated modules. Activation of some modules is specific to particular types of tumor; for example, a growth-inhibitory module is specifically repressed in acute lymphoblastic leukemias and may underlie the deregulated proliferation in these cancers. Other modules are shared across a diverse set of clinical conditions, suggestive of common tumor progression mechanisms. For example, the bone osteoblastic module spans a variety of tumor types and includes both secreted growth factors and their receptors. Our findings suggest that there is a single mechanism for both primary tumor proliferation and metastasis to bone. Our analysis presents multiple research directions for diagnostic, prognostic and therapeutic studies.
引用
收藏
页码:1090 / 1098
页数:9
相关论文
共 30 条
[1]   Gene Ontology: tool for the unification of biology [J].
Ashburner, M ;
Ball, CA ;
Blake, JA ;
Botstein, D ;
Butler, H ;
Cherry, JM ;
Davis, AP ;
Dolinski, K ;
Dwight, SS ;
Eppig, JT ;
Harris, MA ;
Hill, DP ;
Issel-Tarver, L ;
Kasarskis, A ;
Lewis, S ;
Matese, JC ;
Richardson, JE ;
Ringwald, M ;
Rubin, GM ;
Sherlock, G .
NATURE GENETICS, 2000, 25 (01) :25-29
[2]   Metastasis genes: A progression puzzle [J].
Bernards, R ;
Weinberg, RA .
NATURE, 2002, 418 (6900) :823-823
[3]   Bone mineral density in children with acute lymphoblastic leukaemia [J].
Boot, AM ;
van den Heuvel-Eibrink, MM ;
Hählen, K ;
Krenning, EP ;
de Muinck Keizer-Schrama, SMPF .
EUROPEAN JOURNAL OF CANCER, 1999, 35 (12) :1693-1697
[4]   The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation [J].
Chu, YF ;
Solski, PA ;
KhosraviFar, R ;
Der, CJ ;
Kelly, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) :6497-6501
[5]   GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways [J].
Dahlquist, KD ;
Salomonis, N ;
Vranizan, K ;
Lawlor, SC ;
Conklin, BR .
NATURE GENETICS, 2002, 31 (01) :19-20
[6]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[7]   DLX genes as targets of ALL-1:: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias [J].
Ferrari, N ;
Palmisano, GL ;
Paleari, L ;
Basso, G ;
Mangioni, M ;
Fidanza, V ;
Albini, A ;
Croce, CM ;
Levi, G ;
Brigati, C .
JOURNAL OF LEUKOCYTE BIOLOGY, 2003, 74 (02) :302-305
[8]   Potential tumor suppressive pathway involving DUSP6/MKP-3 in pancreatic cancer [J].
Furukawa, T ;
Sunamura, M ;
Motoi, F ;
Matsuno, S ;
Horii, A .
AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (06) :1807-1815
[9]   TAB1β (transforming growth Factor-β-activated protein kinase 1-binding protein 1β), a novel splicing variant of TAB1 that interacts with p38α but not TAK1 [J].
Ge, BX ;
Xiong, XS ;
Jing, Q ;
Mosley, JL ;
Filose, A ;
Bian, DF ;
Huang, S ;
Han, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (04) :2286-2293
[10]   Altered androgen metabolism eventually leads hepatocellular carcinoma to an impaired hormone responsiveness [J].
Granata, OM ;
Carruba, G ;
Montalto, G ;
Miele, M ;
Bellavia, V ;
Modica, G ;
Blomquist, CH ;
Castagnetta, LAM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2002, 193 (1-2) :51-58